BIOCRYST PHARMACEUTICALS INC — SC 13G Filings
44 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by BIOCRYST PHARMACEUTICALS INC (BCRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. BIOCRYST PHARMACEUTICALS INC has filed 44 SC 13G documents with the SEC since 2015. To view all SEC filings by BIOCRYST PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | BIOCRYST PHARMACEUTICALS INC. | 0000902664-24-001592 | Feb 14, 2024 | — |
| SC 13G | SCHEDULE 13G | 0000899140-21-000082 | Jan 25, 2021 | — |
| SC 13G | SC 13G | 0001104659-20-072065 | Jun 10, 2020 | — |
| SC 13G | BIOCRYST PHARMACEUTICALS INC | 0000902664-20-001843 | Apr 17, 2020 | — |
| SC 13G | SCHEDULE 13G | 0000899140-19-000618 | Nov 19, 2019 | — |
| SC 13G | — | 0001319244-19-000051 | May 29, 2019 | — |
| SC 13G | SC 13G | 0001104659-19-008702 | Feb 14, 2019 | — |
| SC 13G | — | 0000930413-19-000073 | Jan 11, 2019 | — |
| SC 13G | SC 13G | 0001144204-18-008996 | Feb 14, 2018 | — |
| SC 13G | JANUS HENDERSON GROUP OWNS OVER 5% | 0001274173-18-000030 | Feb 12, 2018 | — |
| SC 13G | — | 0000932471-18-002706 | Feb 8, 2018 | — |
| SC 13G | — | 0001193805-17-001008 | Jun 5, 2017 | — |
| SC 13G | SC 13G | 0001144204-17-012932 | Mar 6, 2017 | — |
| SC 13G | SCHEDULE 13G | 0001144204-17-001361 | Jan 9, 2017 | — |
| SC 13G | — | 0001493152-16-012897 | Aug 26, 2016 | — |
| SC 13G | SCHEDULE 13G | 0001144204-16-120555 | Aug 22, 2016 | — |
| SC 13G | SCHEDULE 13G | 0001144204-16-120025 | Aug 17, 2016 | — |
| SC 13G | — | 0001193805-16-003727 | Aug 12, 2016 | — |
| SC 13G | SCHEDULE 13G 3-28-16 | 0001596770-16-000128 | Mar 28, 2016 | — |
| SC 13G | SCHEDULE 13G | 0001144204-16-087822 | Mar 14, 2016 | — |
| SC 13G | — | 0001086364-15-001673 | Feb 2, 2015 | — |
| SC 13G | SC 13G | 0001144204-14-011523 | Feb 25, 2014 | — |
| SC 13G | DISCLOSURE DOCUMENT | 0000902219-14-000573 | Feb 14, 2014 | — |
| SC 13G | — | 0000315066-14-001792 | Feb 10, 2014 | — |
| SC 13G | SC 13G | 0001144204-13-044170 | Aug 9, 2013 | — |
| SC 13G | — | 0000919574-13-004274 | Aug 2, 2013 | — |
| SC 13G | — | 0001086364-13-001112 | Jan 30, 2013 | — |
| SC 13G | — | 0001144204-12-015589 | Mar 16, 2012 | — |
| SC 13G | — | 0000905339-10-000016 | May 17, 2010 | — |
| SC 13G | SCHEDULE 13G HOLDINGS REPORT | 0001172661-08-000146 | Feb 14, 2008 | — |
| SC 13G | SCHEDULE 13G RE BIOCRYST PHARMACEUTICALS, INC. 02-12-2007 | 0000906344-07-000167 | Feb 13, 2007 | — |
| SC 13G | SCHEDULE 13G RE BIOCRYST PHARMACEUTICALS, INC. 02-12-2007 | 0000906344-07-000166 | Feb 13, 2007 | — |
| SC 13G | SCHEDULE 13G RE BIOCRYST PHARMACEUTICALS, INC. 02-12-2007 | 0000906344-07-000165 | Feb 13, 2007 | — |
| SC 13G | SCHEDULE 13G RE BIOCRYST PHARMACEUTICALS, INC. 02-12-2007 | 0000906344-07-000168 | Feb 13, 2007 | — |
| SC 13G | SCHEDULE 13G | 0001193805-05-002142 | Oct 25, 2005 | — |
| SC 13G | — | 0000930413-05-001234 | Feb 25, 2005 | — |
| SC 13G | — | 0000891836-05-000155 | Feb 25, 2005 | — |
| SC 13G | BCRX AS OF 12/31/2003 | 0000080255-04-000176 | Feb 9, 2004 | — |
| SC 13G | — | 0001243875-03-000045 | Dec 19, 2003 | — |
| SC 13G | — | 0000898432-03-001086 | Nov 5, 2003 | — |
| SC 13G | — | 0001102899-01-000008 | Feb 14, 2001 | — |
| SC 13G | SCHEDULE 13G | 0000912057-00-046045 | Oct 26, 2000 | — |
| SC 13G | BIOCRYST PHARMACEUTICALS, INC. / MAX COOPER | 0000950144-99-008932 | Jul 16, 1999 | — |
| SC 13G | — | 0000864047-95-000114 | Feb 14, 1995 | — |